TrialBlood2011

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

Aaron P Rapoport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.